Company

TB Alliance

PrivateUnited States

TB Alliance is a global health organization that develops new tuberculosis treatments aimed at creating faster, simpler, and more effective cures. The organization manages the largest pipeline of TB drugs in development and works to ensure these treatments reach patients in need worldwide. TB Alliance addresses antimicrobial resistance and focuses on treatments for drug-resistant TB forms, including child-friendly medicines and long-acting injectables.

TB Alliance is a privately held company, based in the United States. Leadership tracked by CEOInsider includes Maria Freire (CEO).

www.tballiance.org ↗LinkedIn ↗

Leadership

Current

Maria Freire

CEO

Recent developments

AI summary of recent coverage

Recent coverage has focused on Maria Freire's leadership role and her work in advancing drug development initiatives. The headlines reflect Freire's involvement with foundation leadership positions and her expertise in tuberculosis and pharmaceutical innovation, with coverage spanning from her early work on TB drug development through her subsequent roles in research and foundation management.

Summarized from the headlines in the sidebar; see each source for the full story.